Cookie Policy: This site uses cookies to improve your experience. You can find out more about our use of cookies in our Privacy Policy. By continuing to browse this site you agree to our use of cookies.
Bertin Bioreagent
anti-AcSDKP, pAb
As low as
1089
CHF
CHF 1’089.00
In stock
Only %1 left
BRT-A03881-T500500 dtnCHF 1’089.00
NEW
| Product Details | |
|---|---|
| Synonyms | Ac-SDKP; Acetyl-SDKP; N-acetyl-seryl-aspartyl-lysyl-proline; Acetyl-Ser-Asp-Lys-Pro |
| Product Type | Polyclonal Antibody |
| Properties | |
| Source/Host | Rabbit |
| Immunogen/Antigen | AcSDKP-KLH. |
| Application | EIA |
| Formulation | Liquid. In Phosphate Buffer. |
| Other Product Data |
Click here for Original Manufacturer Product Datasheet |
| Declaration | Manufactured by Bertin Bioreagent |
| Shipping and Handling | |
| Shipping | BLUE ICE |
| Long Term Storage | +4°C |
| Use/Stability | Stable for at least 2 years after receipt when stored at -20°C. |
| Documents | |
| Product Specification Sheet | |
| Datasheet |
 Download PDF |
Description
N-Acetyl Ser-Asp-Lys-Pro (AcSDKP) is a tetrapeptide growth regulatory hormone which inhibits the proliferation of hematopoietic stem cells. The dipeptidase Angiotensin Converting Enzyme (ACE) actively metabolizes circulating AcSDKP. ACE inhibition is a major therapeutic end point in the treatment of hypertension management. A further consequence of ACE inhibition is the accumulation of AcSDKP in the plasma and the urine. This accumulation may have physiological effects, which are manifested as the anemia of chronic ACE inhibitor toxicity.